SCHEMBL3756535

SCHEMBL3756535

C[C@H](c1ccccc1)N1C(=O)c2ccc(F)cc2C1C(=O)NCc1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.64
KCNH2 Q12809 2/20 0.42
SCN9A Q15858 2/20 0.42
CYP3A4 P08684 2/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
P2RX7 Q99572 1/20 0.41
SCN5A Q14524 1/20 0.41
NR3C2 P08235 1/20 0.40
DRD2 P14416 1/20 0.39
ELANE P08246 4/20 0.39
PRMT5 O14744 3/20 0.39
WDR77 Q9BQA1 3/20 0.39
OGA O60502 1/20 0.39
CCR5 P51681 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
METAP2 P50579 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3754015 0.91 KCNA5 (0.77) KCNA5KCNH2SCN9ATSHRP2RX7
SCHEMBL3752066 0.90 KCNA5 (0.64) KCNA5KCNH2SCN9ACYP3A4TSHR
SCHEMBL3758908 0.89 KCNA5 (0.69) KCNA5KCNH2SCN9AP2RX7SCN5A
SCHEMBL3747907 0.89 KCNA5 (0.81) KCNA5KCNH2SCN9ACYP3A4TSHR
SCHEMBL3751209 0.81 KCNA5 (0.52) KCNA5KCNH2SCN9ACYP3A4TSHR
SCHEMBL3744033 0.81 KCNA5 (0.80) KCNA5KCNH2SCN9AP2RX7SCN5A
SCHEMBL3748956 0.81 KCNA5 (0.66) KCNA5KCNH2SCN9ACYP3A4TSHR
SCHEMBL3750669 0.80 KCNA5 (0.86) KCNA5KCNH2SCN9ATSHRP2RX7
SCHEMBL3752007 0.80 KCNA5 (0.55) KCNA5TSHRP2RX7
SCHEMBL3752643 0.80 KCNA5 (0.81) KCNA5KCNH2SCN9ATSHRP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias ASTRAZENECA AB (SE) 2010-11-25 US claimed
US-20080015237-A1 NEW COMPOUNDS I/418 ASTRAZENECA AB (SE) 2008-01-17 US claimed
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias ASTRAZENECA AB (SE) 2010-11-25 US disclosed
US-20080015237-A1 NEW COMPOUNDS I/418 ASTRAZENECA AB (SE) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015237-A1 NEW COMPOUNDS I/418 KCNH1, KCNH2, KCNH3 KCNA5 69/4885KCNH2 2/4885SCN9A 119/4885
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias KCNH1, KCNH2, KCNQ2 KCNA5 72/4885KCNH2 2/4885SCN9A 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.